These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35786124)

  • 1. Industrializing AI-powered drug discovery: lessons learned from the
    Guedj M; Swindle J; Hamon A; Hubert S; Desvaux E; Laplume J; Xuereb L; Lefebvre C; Haudry Y; Gabarroca C; Aussy A; Laigle L; Dupin-Roger I; Moingeon P
    Expert Opin Drug Discov; 2022 Aug; 17(8):815-824. PubMed ID: 35786124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence in early drug discovery enabling precision medicine.
    Boniolo F; Dorigatti E; Ohnmacht AJ; Saur D; Schubert B; Menden MP
    Expert Opin Drug Discov; 2021 Sep; 16(9):991-1007. PubMed ID: 34075855
    [No Abstract]   [Full Text] [Related]  

  • 3. Artificial Intelligence for Precision Oncology.
    Bhalla S; Laganà A
    Adv Exp Med Biol; 2022; 1361():249-268. PubMed ID: 35230693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Learning in Drug Discovery and Medicine; Scratching the Surface.
    Dana D; Gadhiya SV; St Surin LG; Li D; Naaz F; Ali Q; Paka L; Yamin MA; Narayan M; Goldberg ID; Narayan P
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30231499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using artificial intelligence methods to speed up drug discovery.
    Álvarez-Machancoses Ó; Fernández-Martínez JL
    Expert Opin Drug Discov; 2019 Aug; 14(8):769-777. PubMed ID: 31140873
    [No Abstract]   [Full Text] [Related]  

  • 6. Artificial intelligence in drug discovery: recent advances and future perspectives.
    Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
    Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
    [No Abstract]   [Full Text] [Related]  

  • 7. Industrializing AI/ML during the end-to-end drug discovery process.
    Yoo J; Kim TY; Joung I; Song SO
    Curr Opin Struct Biol; 2023 Apr; 79():102528. PubMed ID: 36736243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The machine learning life cycle and the cloud: implications for drug discovery.
    Spjuth O; Frid J; Hellander A
    Expert Opin Drug Discov; 2021 Sep; 16(9):1071-1079. PubMed ID: 34057379
    [No Abstract]   [Full Text] [Related]  

  • 10. Artificial Intelligence for Autonomous Molecular Design: A Perspective.
    Joshi RP; Kumar N
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence-enhanced drug design and development: Toward a computational precision medicine.
    Moingeon P; Kuenemann M; Guedj M
    Drug Discov Today; 2022 Jan; 27(1):215-222. PubMed ID: 34555509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Applications of artificial intelligence to new drug development].
    Moingeon P
    Ann Pharm Fr; 2021 Sep; 79(5):566-571. PubMed ID: 33529579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Looking beyond the hype: Applied AI and machine learning in translational medicine.
    Toh TS; Dondelinger F; Wang D
    EBioMedicine; 2019 Sep; 47():607-615. PubMed ID: 31466916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Computational Biology and Artificial Intelligence Technologies in Cancer Precision Drug Discovery.
    Nagarajan N; Yapp EKY; Le NQK; Kamaraj B; Al-Subaie AM; Yeh HY
    Biomed Res Int; 2019; 2019():8427042. PubMed ID: 31886259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational precision medicine: an industry perspective.
    Hartl D; de Luca V; Kostikova A; Laramie J; Kennedy S; Ferrero E; Siegel R; Fink M; Ahmed S; Millholland J; Schuhmacher A; Hinder M; Piali L; Roth A
    J Transl Med; 2021 Jun; 19(1):245. PubMed ID: 34090480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-based computational precision medicine to develop combination therapies for autoimmune diseases.
    Desvaux E; Aussy A; Hubert S; Keime-Guibert F; Blesius A; Soret P; Guedj M; Pers JO; Laigle L; Moingeon P
    Expert Rev Clin Immunol; 2022 Jan; 18(1):47-56. PubMed ID: 34842494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How can artificial intelligence be used for peptidomics?
    Perpetuo L; Klein J; Ferreira R; Guedes S; Amado F; Leite-Moreira A; Silva AMS; Thongboonkerd V; Vitorino R
    Expert Rev Proteomics; 2021 Jul; 18(7):527-556. PubMed ID: 34343059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine.
    Pun FW; Leung GHD; Leung HW; Liu BHM; Long X; Ozerov IV; Wang J; Ren F; Aliper A; Izumchenko E; Moskalev A; de Magalhães JP; Zhavoronkov A
    Aging (Albany NY); 2022 Mar; 14(6):2475-2506. PubMed ID: 35347083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Intelligence and Quantum Computing as the Next Pharma Disruptors.
    Cova T; Vitorino C; Ferreira M; Nunes S; Rondon-Villarreal P; Pais A
    Methods Mol Biol; 2022; 2390():321-347. PubMed ID: 34731476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical assessment of AI in drug discovery.
    Walters WP; Barzilay R
    Expert Opin Drug Discov; 2021 Sep; 16(9):937-947. PubMed ID: 33870801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.